USPTO trademark

OJEMDA

RegisteredUSPTOWord markClass 5Class 42Class 44

"OJEMDA" is a word mark owned by Day One Biopharmaceuticals, Inc., filed at the USPTO on June 6, 2023. It is registered and covers classes 5, 42 and 44.

View Day One Biopharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
OJEMDA trademark as filed
As filed with the USPTO
Status
Registered
Since July 22, 2025
Filed
June 6, 2023
Registered
July 22, 2025
Expires
Not recorded
Application no.
98030463
Registration no.
7871167
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns OJEMDA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Day One Biopharmaceuticals, Inc.

DAWN · Brisbane, United States

17 trademarks in the portfolioView company

Representative

Maury M. Tepper, III

Tepper & Eyster, PLLC

Goods and services

What the mark covers

The products and services OJEMDA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders

  • Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders

  • Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Notice of registration confirmation emailed
  7. Registered-principal register
  8. Notice of acceptance of statement of use e-mailed
  9. Allowed principal register - sou accepted
  10. Case assigned to intent to use paralegal

10 earlier steps on the official record.

FAQ

About OJEMDA

Who owns the trademark "OJEMDA"?

The USPTO trademark "OJEMDA" (application 98030463) is owned by Day One Biopharmaceuticals, Inc.

What is the status of "OJEMDA"?

Its status at the USPTO is: registered.

When was "OJEMDA" registered?

It was registered on July 22, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OJEMDA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bcb-9393-706d-a6ca-78769983da27
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bcb-9393-706d-a6ca-78769983da27",
  "object": "trademark",
  "mark_text": "OJEMDA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98030463",
  "filing_date": "2023-06-06",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Day One Biopharmaceuticals, Inc.",
      "entity_id": "ent_019eb70d-dcad-750c-ae09-14c47ca4aad6"
    }
  ]
}